Why is Nidan Laborator. falling/rising?

As of 22-Sep, Nidan Laboratories & Healthcare Ltd is experiencing a decline in its stock price, currently at 19.00, which reflects a decrease of 0.1 or 0.52%. The stock's performance today is in line with the sector, and while it is higher than the 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a positive return of 2.15%, which is better than the Sensex's return of 0.53%. However, the stock has significantly underperformed over the longer term, with a year-to-date decline of 34.14% and a staggering 69.38% drop over the past three years. Additionally, the company has not declared results in the last six months, indicating weak long-term fundamental strength, and its ability to service debt is concerning, as reflected by a poor EBIT to Interest ratio of 1.75.
In the broader market context, while Nidan Laboratories has shown some short-term resilience, its long-term performance remains troubling compared to the benchmark. The stock's 1-year return of -43.70% starkly contrasts with the Sensex's modest decline of 2.28%, highlighting consistent underperformance. Despite a recent increase in investor participation, as evidenced by a 33.33% rise in delivery volume, the overall financial health of the company, characterized by a low Return on Equity and declining profits, suggests that the stock's recent movements may not be sustainable. The combination of weak fundamentals and a lack of positive catalysts continues to weigh heavily on the stock's price.